China’s Latest National Drug Procurement Shifts Focus from Lowest Price to Quality and Value, Pharma Stocks Rally on Anti-Involution Effort
China’s Latest National Drug Procurement Shifts Focus from Lowest Price to Quality and Value, Pharma Stocks Rally on Anti-Involution Effort